Drawing for BIO SOLUTIONS

USPTO serial 98064413

BIO SOLUTIONS

Reviewed by CopyMark Law Group

Status 614
Filing date
Status date
Registration date
—
Examiner
CORDANI, CAITLIN A
Law office
PETITIONS OFFICE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BIO SOLUTIONS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeremy A Smith

Jeremy A Smith LANIER FORD SHAVER & PAYNE, PC2101 WEST CLINTON AVENUESUITE 102HUNTSVILLE, AL 35805

Goods and services

ClassDescriptionStatusFirst use
020Desks; Office desks; Standing desksACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 18, 2026PETDPETITION TO REVIVE-DENIED—
Jul 10, 2026PINMINCOMPLETE PETITION NOTICE MAILED—
Jul 9, 2026APETASSIGNED TO PETITION STAFF—
Jun 22, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 19, 2026PETRPETITION TO REVIVE-RECEIVED—
Mar 19, 2026TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Mar 19, 2026NREVNOTICE OF REVIVAL - E-MAILED—
Mar 19, 2026PETGPETITION TO REVIVE-GRANTED—
Mar 19, 2026PROATEAS PETITION TO REVIVE RECEIVED—
Jan 19, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 19, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 15, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 2, 2025EX2GSOU EXTENSION 2 GRANTED—
Jun 2, 2025EXT2SOU EXTENSION 2 FILED—
Jun 2, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 3, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 19, 2024EX1GSOU EXTENSION 1 GRANTED—
Dec 18, 2024EXT1SOU EXTENSION 1 FILED—
Dec 18, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 18, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 23, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 23, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 3, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 20, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 14, 2024DOCKASSIGNED TO EXAMINER—
Jul 31, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 3, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance